Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2018-01-31 | 2018-07-03 | 37717 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2018-01-31 | 2018-11-23 | 37726 |
APO-CIPROFLOX | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-09 | 37729 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-01-31 | 2018-05-09 | 37737 |
APO-QUINAPRIL | 5MG | TABLET | Resolved | 2018-01-31 | 2018-05-25 | 37740 |
APO-TERAZOSIN | 1MG | TABLET | Resolved | 2018-01-31 | 2018-07-31 | 37743 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-21 | 37746 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2018-01-31 | 2018-05-16 | 37749 |
APO-AMLODIPINE-ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2018-02-01 | 2018-07-03 | 37945 |
APO-ENALAPRIL | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37949 |
APO-ENALAPRIL | 5MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37953 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-23 | 37956 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37974 |
APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-02-01 | 2018-04-17 | 37977 |
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-02-01 | 2018-04-24 | 37980 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2018-02-01 | 2018-05-15 | 37983 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-02-01 | 2018-08-20 | 37986 |
APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37989 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2018-02-01 | 2018-05-25 | 37997 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |